Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01640704 · ClinicalTrials.gov registry record · Phase 1

Impact of Computerized Reminders on Blood Pressure Documentation and Control

A Phase 1 study, sponsored by Agency for Healthcare Research and Quality (AHRQ).

Completed
Registry status
Phase 1
Development phase

NCT01640704 is a Phase 1 study that has completed, run by Agency for Healthcare Research and Quality (AHRQ).

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01640704, a Phase 1 study, has completed, sponsored by Agency for Healthcare Research and Quality (AHRQ).

COMPLETED
Registry status
Phase 1
Development phase

Study Summary

Numerous studies have examined potential causes for the racial differences in HTN prevalence and severity including baseline insulin levels, sympathetic nervous activity, intracellular calcium levels and intracellular sodium levels.\[21-23\] However, to our knowledge, there have been no studies examining the relationship of physician adherence to JNC guidelines to racial disparities in outcomes from HTN; nor have there been published studies examining the use of interventions such as computerized decision support tools or case-management to improve JNC adherence with the goal of reducing racial differences in blood pressure control. The aims of this study are: 1) To determine if physician's prescribing practices for HTN medications adhere to JNC guidelines for drug therapy. 2\) To determine if there are variations in adherence to JNC guidelines based on patient race. 3\) To determine if adherence to JNC guidelines improves blood pressure control. 4) To determine if the use of computerized medical reminders improves adherence to JNC guidelines.

Interventions

  • BEHAVIORAL Computerized reminders about treatment guidelines to providers who care for hypertensive patients

Trial Details

FieldValue
Start Date 2003-07
Est. Completion 2005-02
Phase Phase 1

What the Registry Record Tells You About NCT01640704

The ClinicalTrials.gov registry entry for NCT01640704 describes a study currently listed as completed, categorized as Phase 1. An enrollment target was not published in the registry record, which is common for early-stage or observational entries. The listed sponsor is Agency for Healthcare Research and Quality (AHRQ), which has 20 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Computerized reminders about treatment guidelines to providers who care for hypertensive patients is the first listed.

NCT01640704 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT01640704 about?

NCT01640704 is a clinical study titled "Impact of Computerized Reminders on Blood Pressure Documentation and Control". Numerous studies have examined potential causes for the racial differences in HTN prevalence and severity including baseline insulin levels, sympathetic nervous activity, intracellular calcium levels and intracellular sodium levels.\[21-23\] However, to our knowledge, there have been no studies exam...

What is the current status of trial NCT01640704?

This trial is currently completed. It is a Phase 1 study. The study started on 2003-07. Estimated completion is 2005-02.

What interventions are being tested in trial NCT01640704?

The interventions under investigation include: Computerized reminders about treatment guidelines to providers who care for hypertensive patients (BEHAVIORAL).

Who is sponsoring clinical trial NCT01640704?

This trial is sponsored by Agency for Healthcare Research and Quality (AHRQ), which has 20 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.